2022
Catheter ablation of ventricular tachycardia in dilated-phase hypertrophic cardiomyopathy: Substrate characterization and ablation outcome
الباحثونQasim J. Naeemah، Yuki Komatsu
المجلةPace Pacing and Clinical Electrophysiology
التاريخ2022-04-16
مختصر البحث
Introduction Catheter ablation is a therapeutic option to suppress ventricular tachycardia (VT) in the setting of dilated-phase hypertrophic cardiomyopathy (DHCM). However, the characteristics of the arrhythmogenic substrate and the ablation outcome are not fully illustrated.